{
    "id": 20921,
    "fullName": "MAP2K1 Y130C",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "MAP2K1 Y130C lies within the protein kinase domain of the Map2k1 protein (UniProt.org). Y130C demonstrates phosphorylation profile similar to wild-type Map2k1 (PMID: 29753091), and results in increased Erk phosphorylation in cell culture (PMID: 16439621, PMID: 18060073, PMID: 17981815).",
            "references": [
                {
                    "id": 6041,
                    "pubMedId": 17981815,
                    "title": "Germline mutations of MEK in cardio-facio-cutaneous syndrome are sensitive to MEK and RAF inhibition: implications for therapeutic options.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/17981815"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 11574,
                    "pubMedId": 29753091,
                    "title": "Increase in constitutively active MEK1 species by introduction of MEK1 mutations identified in cancers.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29753091"
                },
                {
                    "id": 475,
                    "pubMedId": 18060073,
                    "title": "Mutation analysis of BRAF, MEK1 and MEK2 in 15 ovarian cancer cell lines: implications for therapy.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/18060073"
                },
                {
                    "id": 5839,
                    "pubMedId": 16439621,
                    "title": "Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/16439621"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5604,
        "geneSymbol": "MAP2K1",
        "terms": [
            "MAP2K1",
            "CFC3",
            "MAPKK1",
            "MEK1",
            "MKK1",
            "PRKMK1"
        ]
    },
    "variant": "Y130C",
    "createDate": "04/11/2016",
    "updateDate": "10/25/2019",
    "referenceTranscriptCoordinates": {
        "id": 173544,
        "transcript": "NM_002755",
        "gDna": "chr15:g.66436843A>G",
        "cDna": "c.389A>G",
        "protein": "p.Y130C",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        
    ],
    "molecularProfiles": [
        {
            "id": 21427,
            "profileName": "MAP2K1 Y130C",
            "profileTreatmentApproaches": [
                {
                    "id": 10672,
                    "name": "MEK inhibitor (Pan)",
                    "profileName": "MAP2K1 Y130C"
                },
                {
                    "id": 10673,
                    "name": "MEK1 Inhibitor",
                    "profileName": "MAP2K1 Y130C"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 173545,
            "transcript": "XM_017022411",
            "gDna": "chr15:g.66436843A>G",
            "cDna": "c.389A>G",
            "protein": "p.Y130C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 173544,
            "transcript": "NM_002755",
            "gDna": "chr15:g.66436843A>G",
            "cDna": "c.389A>G",
            "protein": "p.Y130C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}